X
KEY PRODUCTS KEY SERVICES
Details:
Ondansetron Oro-Dispersible Tablet is pleasant and convenient as a tablet that melts in mouth and can be administered anytime anywhere with or without water,is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment.
Lead Product(s): Ondansetron
Therapeutic Area: Gastroenterology Product Name: Ondansetron-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 15, 2022
Details:
Under the terms of the agreement, ATHENA Pharmaceutiques will manage the development and manufacturing of NFL-301, a natural drug candidate from NFL Biosciences aimed at reducing alcohol consumption, while NFL Biosciences will draw up and lead the clinical program.
Lead Product(s): NFL-301
Therapeutic Area: Psychiatry/Psychology Product Name: NFL-301
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: NFL Biosciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 02, 2022
Details:
ATHENA Pharmaceutiques has acquire the Bisoprolol + Aspirin Capsules dossier as well as the patent for this product. It is a fixed dose combination of two reference agents improving compliance and adherence to treatment in the secondary prevention of cardiovascular disease.
Lead Product(s): Bisoprolol Fumarate,Aspirin
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Bisoprolol/Aspirin-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Undisclosed
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition October 15, 2021
Details:
Levocetirizine ODT is second-generation piperazine derivative with potent H1-selective antihistaminic activity,n Improved oral bioavailability and onset of action vs. conventional oral slide form by avoiding hepatic first-pass effect.
Lead Product(s): Levocetirizine Dihydrochloride
Therapeutic Area: Immunology Product Name: Levocetirizine-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 12, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
